{"id":"NCT00048568","sponsor":"Bristol-Myers Squibb","briefTitle":"A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate","officialTitle":"A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study and Open-Label Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy With Methotrexate Versus Methotrexate Alone in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-12","primaryCompletion":"2009-10","completion":"2009-10","firstPosted":"2002-11-13","resultsPosted":"2011-12-05","lastUpdate":"2011-12-05"},"enrollment":1250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Abatacept","otherNames":["BMS-188667"]},{"type":"DRUG","name":"Methotrexate","otherNames":["MTX"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Abatacept + Methotrexate","type":"EXPERIMENTAL"},{"label":"Placebo + Methotrexate","type":"ACTIVE_COMPARATOR"},{"label":"Abatacept + Methotrexate Open Label","type":"EXPERIMENTAL"}],"summary":"Short Term: The purpose of this clinical research study is to learn if abatacept (BMS-188667) in combination with methotrexate is better than methotrexate alone in participants that have active rheumatoid arthritis and are not responding to methotrexate. The safety of this treatment will also be studied.\n\nLong Term Extension: The purpose of this amendment is to provide participants who have completed the initial 12-month double-blind treatment period the opportunity to receive open label treatment with active drug treatment until abatacept is approved in the local country or until clinical development has been discontinued.","primaryOutcome":{"measure":"Number of American College of Rheumatology 20 (ACR 20) Responders at Day 169","timeFrame":"Day 169","effectByArm":[{"arm":"ABA + MTX DB","deltaMin":288,"sd":null},{"arm":"MTX + Placebo DB","deltaMin":85,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":48,"countries":["United States"]},"refs":{"pmids":["16785475","24786925","18383390"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":215,"n":539},"commonTop":["NASOPHARYNGITIS","HEADACHE","UPPER RESPIRATORY TRACT INFECTION","BACK PAIN","DIARRHOEA"]}}